Form 4: NeoGenomics CEO Christopher Smith Reports Stock Transactions
SEC Form 4 Filing
CEO Christopher Smith of NeoGenomics Inc. reports disposition of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On August 15, 2024, Christopher M. Smith, CEO of NeoGenomics Inc., reported a transaction involving the disposition of 33,130 shares of common stock to cover tax obligations related to the vesting of restricted stock.
- Following the transaction, Smith directly owns 646,302 shares of NeoGenomics Inc.
- Smith also holds various stock options, restricted stock units, and performance stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, and the transaction is related to tax obligations, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure related to executive compensation and does not necessarily indicate a change in the company's outlook or performance.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 08/15/2022 | Mr. Smith was granted 694,444 stock options. |
| 05/11/2023 | Mr. Smith was granted 269,841 stock options and 144,190 restricted stock units. |
| 05/11/2026 | Expiration date for performance stock units granted on May 11, 2023. |
| 02/23/2024 | Mr. Smith was granted 287,940 stock options, 172,239 restricted stock units, and 172,240 performance stock units. |
| 02/23/2027 | Expiration date for performance stock units granted on February 23, 2024. |
| 08/15/2024 | Transaction date: Disposition of 33,130 shares for tax obligations. |
| 08/15/2029 | Expiration date for stock options granted on August 15, 2022. |
| 05/11/2030 | Expiration date for stock options granted on May 11, 2023. |
| 02/23/2034 | Expiration date for stock options granted on February 23, 2024. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.